Monti S - Search Results

1

SYK inhibition modulates distinct PI3K/AKT- dependent survival pathways and cholesterol biosynthesis in diffuse large B cell lymphomas.

Chen L, Monti S, Juszczynski P, Ouyang J, Chapuy B, Neuberg D, Doench JG, Bogusz AM, Habermann TM, Dogan A, Witzig TE, Kutok JL, Rodig SJ, Golub T, Shipp MA. Chen L, et al. Among authors: monti s. Cancer Cell. 2013 Jun 10;23(6):826-38. doi: 10.1016/j.ccr.2013.05.002. Cancer Cell. 2013. PMID: 23764004 Free PMC article.

2

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, Kurtin P, Dal Cin P, Ladd C, Feuerhake F, Aguiar RC, Li S, Salles G, Berger F, Jing W, Pinkus GS, Habermann T, Dalla-Favera R, Harris NL, Aster JC, Golub TR, Shipp MA. Savage KJ, et al. Among authors: monti s. Blood. 2003 Dec 1;102(12):3871-9. doi: 10.1182/blood-2003-06-1841. Epub 2003 Aug 21. Blood. 2003. PMID: 12933571 Free article.

3

A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer.

Halmos B, Bassères DS, Monti S, D'Aló F, Dayaram T, Ferenczi K, Wouters BJ, Huettner CS, Golub TR, Tenen DG. Halmos B, et al. Among authors: monti s. Cancer Res. 2004 Jun 15;64(12):4137-47. doi: 10.1158/0008-5472.CAN-03-4052. Cancer Res. 2004. PMID: 15205324

4

Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.

Monti S, Savage KJ, Kutok JL, Feuerhake F, Kurtin P, Mihm M, Wu B, Pasqualucci L, Neuberg D, Aguiar RC, Dal Cin P, Ladd C, Pinkus GS, Salles G, Harris NL, Dalla-Favera R, Habermann TM, Aster JC, Golub TR, Shipp MA. Monti S, et al. Blood. 2005 Mar 1;105(5):1851-61. doi: 10.1182/blood-2004-07-2947. Epub 2004 Nov 18. Blood. 2005. PMID: 15550490 Free article.

5

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.

Feuerhake F, Kutok JL, Monti S, Chen W, LaCasce AS, Cattoretti G, Kurtin P, Pinkus GS, de Leval L, Harris NL, Savage KJ, Neuberg D, Habermann TM, Dalla-Favera R, Golub TR, Aster JC, Shipp MA. Feuerhake F, et al. Among authors: monti s. Blood. 2005 Aug 15;106(4):1392-9. doi: 10.1182/blood-2004-12-4901. Epub 2005 May 3. Blood. 2005. PMID: 15870177 Free article.

6

Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma.

Takahashi H, Feuerhake F, Monti S, Kutok JL, Aster JC, Shipp MA. Takahashi H, et al. Among authors: monti s. Blood. 2006 Jan 15;107(2):844-5. doi: 10.1182/blood-2005-07-2827. Blood. 2006. PMID: 16401828 Free article. No abstract available.

7

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.

Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV, Aster JC, Murty VV, Shipp MA, Dalla-Favera R. Pasqualucci L, et al. Among authors: monti s. J Exp Med. 2006 Feb 20;203(2):311-7. doi: 10.1084/jem.20052204. J Exp Med. 2006. PMID: 16492805 Free PMC article.

8

FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.

Takahashi H, Feuerhake F, Kutok JL, Monti S, Dal Cin P, Neuberg D, Aster JC, Shipp MA. Takahashi H, et al. Among authors: monti s. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3265-71. doi: 10.1158/1078-0432.CCR-06-0076. Clin Cancer Res. 2006. PMID: 16740746

9

Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling.

Kobayashi S, Shimamura T, Monti S, Steidl U, Hetherington CJ, Lowell AM, Golub T, Meyerson M, Tenen DG, Shapiro GI, Halmos B. Kobayashi S, et al. Among authors: monti s. Cancer Res. 2006 Dec 1;66(23):11389-98. doi: 10.1158/0008-5472.CAN-06-2318. Cancer Res. 2006. PMID: 17145885

10

Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas.

Polo JM, Juszczynski P, Monti S, Cerchietti L, Ye K, Greally JM, Shipp M, Melnick A. Polo JM, et al. Among authors: monti s. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3207-12. doi: 10.1073/pnas.0611399104. Epub 2007 Feb 20. Proc Natl Acad Sci U S A. 2007. PMID: 17360630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

828 results

Search Page

Filters